AMPK and Insulin Action - Responses to Ageing and High Fat Diet

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Frøsig, Christian ^a   Jensen, Thomas E ^a   Jeppesen, Jacob ^a   Pehmøller, Christian ^a   Treebak, Jonas T ^a,c   Maarbjerg, Stine J ^a,d   Kristensen, Jonas M ^a,e   Sylow, Lykke ^a   Alsted, Thomas J ^a   Schjerling, Peter ^b   Kiens, Bente ^a   Wojtaszewski, Jørgen F P ^a   Richter, Erik A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Capital Region   (Denmark)

^d NOVO NORDISK A S   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; MEMBRANE PROTEIN; PROTEIN KINASE B; PROTEIN TBC1D1; PROTEIN TBC1D4; UNCLASSIFIED DRUG;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXTENSOR DIGITORUM LONGUS MUSCLE; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HORMONE ACTION; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOLEUS MUSCLE; TISSUE SPECIFICITY; WILD TYPE;

AGING; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; BODY COMPOSITION; DIET, HIGH-FAT; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; GTPASE-ACTIVATING PROTEINS; HEXOKINASE; HOMEOSTASIS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MUSCLE PROTEINS; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT;

MUS;

EID: 84877089184     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062338     Document Type: Article

References (40)

1. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, et al. (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000-1007.
2. Hotamisligil GS, (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
3. Savage DB, Petersen KF, Shulman GI, (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87: 507-520.
4. Bruce CR, Hoy AJ, Turner N, Watt MJ, Allen TL, et al. (2009) Overexpression of carnitine palmitoyltransferase-1 in skeletal muscle is sufficient to enhance fatty acid oxidation and improve high-fat diet-induced insulin resistance. Diabetes 58: 550-558.
5. Choi CS, Savage DB, Abu-Elheiga L, Liu ZX, Kim S, et al. (2007) Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci U S A 104: 16480-16485.
6. Treebak JT, Wojtaszewski JF, (2008) Role of 5′AMP-activated protein kinase in skeletal muscle. Int J Obes (Lond) 32Suppl 4: S13-S17.
7. Hardie DG, (2011) AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 25: 1895-1908.
8. Richter EA, Ruderman NB, (2009) AMPK and the biochemistry of exercise: implications for human health and disease. Biochem J 418: 261-275.
9. Hardie DG, (2004) AMP-activated protein kinase: a master switch in glucose and lipid metabolism. Rev Endocr Metab Disord 5: 119-125.
10. Davies SP, Sim AT, Hardie DG, (1990) Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase. Eur J Biochem 187: 183-190.
11. Merrill GF, Kurth EJ, Hardie DG, Winder WW, (1997) AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 273: E1107-E1112.
12. Fujii N, Ho RC, Manabe Y, Jessen N, Toyoda T, et al. (2008) Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice. Diabetes 57: 2958-2966.
13. Fujii N, Seifert MM, Kane EM, Peter LE, Ho RC, et al. (2007) Role of AMP-activated protein kinase in exercise capacity, whole body glucose homeostasis, and glucose transport in skeletal muscle-insight from analysis of a transgenic mouse model-. Diabetes Res Clin Pract 77Suppl 1: S92-S98.
14. Beck JS, O'Neill HM, Hewitt K, Kemp BE, Steinberg GR, (2009) Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetologia 52: 2395-2404.
15. Mu J, Brozinick JT, Valladares O, Bucan M, Birnbaum MJ, (2001) A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7: 1085-1094.
16. Mu J, Barton ER, Birnbaum MJ, (2003) Selective suppression of AMP-activated protein kinase in skeletal muscle: update on 'lazy mice'. Biochem Soc Trans 31: 236-241.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
18. Chen S, Murphy J, Toth R, Campbell DG, Morrice NA, et al. (2008) Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J 409: 449-459.
19. Vind BF, Birk JB, Vienberg SG, Andersen B, Beck-Nielsen H, et al. (2012) Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes. Diabetologia 55: 1435-1445.
20. Cartee GD, Wojtaszewski JF, (2007) Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport. Appl Physiol Nutr Metab 32: 557-566.
21. Sakamoto K, Holman GD, (2008) Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am J Physiol Endocrinol Metab 295: E29-E37.
22. Lauritzen HP, Ploug T, Ai H, Donsmark M, Prats C, et al. (2008) Denervation and high-fat diet reduce insulin signaling in T-tubules in skeletal muscle of living mice. Diabetes 57: 13-23.
23. Zierath JR, Houseknecht KL, Gnudi L, Kahn BB, (1997) High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes 46: 215-223.
24. Perreault M, Marette A, (2001) Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7: 1138-1143 10.1038/nm1001-1138 [doi];nm1001-1138 [pii].
25. Morino K, Neschen S, Bilz S, Sono S, Tsirigotis D, et al. (2008) Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle. Diabetes 57: 2644-2651.
26. Standaert ML, Sajan MP, Miura A, Kanoh Y, Chen HC, et al. (2004) Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states. J Biol Chem 279: 24929-24934.
27. Chen S, Wasserman DH, Mackintosh C, Sakamoto K, (2011) Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking. Cell Metab 13: 68-79.
28. Turdi S, Kandadi MR, Zhao J, Huff AF, Du M, et al. (2011) Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J Mol Cell Cardiol 50: 712-722.
29. Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J, (2008) Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 295: E1323-E1332.
30. Escriva F, Agote M, Rubio E, Molero JC, Pascual-Leone AM, et al. (1997) In vivo insulin-dependent glucose uptake of specific tissues is decreased during aging of mature Wistar rats. Endocrinology 138: 49-54.
31. Manetta J, Brun JF, Callis A, Mercier J, Prefaut C, (2001) Insulin and non-insulin-dependent glucose disposal in middle-aged and young athletes versus sedentary men. Metabolism 50: 349-354.
32. Broome CS, Kayani AC, Palomero J, Dillmann WH, Mestril R, et al. (2006) Effect of lifelong overexpression of HSP70 in skeletal muscle on age-related oxidative stress and adaptation after nondamaging contractile activity. FASEB J 20: 1549-1551.
33. Gupte AA, Bomhoff GL, Geiger PC, (2008) Age-related differences in skeletal muscle insulin signaling: the role of stress kinases and heat shock proteins. J Appl Physiol 105: 839-848.
34. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, et al. (2002) Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 51: 2951-2958.
35. Fujii N, Hirshman MF, Kane EM, Ho RC, Peter LE, et al. (2005) AMP-activated protein kinase alpha2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle. J Biol Chem 280: 39033-39041 M504208200 [pii];10.1074/jbc.M504208200 [doi].
36. Maarbjerg SJ, Jorgensen SB, Rose AJ, Jeppesen J, Jensen TE, et al. (2009) Genetic impairment of AMPKalpha2 signaling does not reduce muscle glucose uptake during treadmill exercise in mice. Am J Physiol Endocrinol Metab 297: E924-E934.
37. Hu CC, Qing K, Chen Y, (2004) Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and-resistant mice. Obes Res 12: 1264-1270.
38. Du K, Herzig S, Kulkarni RN, Montminy M, (2003) TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300: 1574-1577.
39. Koh HJ, Arnolds DE, Fujii N, Tran TT, Rogers MJ, et al. (2006) Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol Cell Biol 26: 8217-8227.
40. Matos A, Ropelle ER, Pauli JR, Frederico MJ, de Pinho RA, et al. (2010) Acute exercise reverses TRB3 expression in the skeletal muscle and ameliorates whole body insulin sensitivity in diabetic mice. Acta Physiol (Oxf) 198: 61-69.